3D Imaging Drug Design and Development LLC

----------

These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection.

Fludeoxyglucose F18 Injection
Initial U.S. Approval: 2015

Labeler - 3D Imaging Drug Design and Development LLC (802267471)
Establishment
NameAddressID/FEIBusiness Operations
3D Imaging Drug Design and Development LLC802267471positron emission tomography drug production(76451-118)

Revised: 7/2018
Document Id: 08281fe0-a1d7-481e-95a8-b7043e88ba48
Set id: 2785ce60-86c9-42c2-ab0a-8c5d5adf60d3
Version: 1
Effective Time: 20180706
 
3D Imaging Drug Design and Development LLC